Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MF/Formoterol versus fluticasone/salmeterol in persistent asthma
2006-004169-33Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- Mar 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in persistent asthma comparing Mometasone furoate/formoterol BID with Fluticasone propionate/salmeterol BID (2 arms). Primary endpoint: Primary efficacy endpoint. Started Mar 2007; status: terminated.
02
Drugs
mometasoneformoterolfluticasone propionatesalmeterol
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2006-004169-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004169-33.